Acquisition of Six Medications for the Regional Sucre Requested by Pharmacy Headquarters

BoliviaTenders notice for Acquisition of Six Medications for the Regional Sucre Requested by Pharmacy Headquarters. The reference ID of the tender is 114880015 and it is closing on 19 Feb 2025.

100% Secure Payments

Tender Details

  • Country: Bolivia
  • Summary: Acquisition of Six Medications for the Regional Sucre Requested by Pharmacy Headquarters
  • BOT Ref No: 114880015
  • Deadline: 19 Feb 2025
  • Competition: ICB
  • Financier: Self Financed
  • Purchaser Ownership: Public
  • Tender Value: Refer Document
  • Notice Type: Tender
  • Document Ref. No.: 25-0417-06-1524558-1-1
  • Purchaser's Detail :
  • Purchaser : NATIONAL HEALTH FUND (REGIONAL CHUQUISACA)
    Sara Gabriela Betanzos Andrade (TELF 6461501)

  • Description :
  • The bidders are invited to acquisition of six medications for the regional Sucre requested by the Head of Pharmacy
    State: in force
    Entity: National Health Caja (Regional Chuquisaca)
    Department: Chuquisaca
    Publication date: February 14, 2025
    Modality: Minor hiring
  • Documents :
  •  Tender Notice

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN
BoliviaTenders Features

BoliviaTenders Features

Fresh and verified Tenders from Bolivia. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.

  • 1,000+ Tenders
  • Verified Tenders Only
  • Accurate Tender Information
  • New Tenders Every Day
  • Consultants for RFI/RFP/RFQ
  • Search, sort, and filter Tenders
  • Customer Support
  • Publish your Tenders
  • Consulting Services
  • Export data to Excel or CRM

Get A Call From Tender Experts

Fill out the form below and you will receive a call from us within 24 hours.

Thank You for Contacting ZimbabweTenders !!
Email Id is already exist !!
Invalid Captcha !

Get FREE SAMPLE TENDERS from Bolivia in your email inbox.

  Chat with us